Matthew Eadens
Overview
Explore the profile of Matthew Eadens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
355
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haddad T, Qin R, Lupu R, Satele D, Eadens M, Goetz M, et al.
Cancer Chemother Pharmacol
. 2017 May;
79(6):1221-1227.
PMID: 28477227
Purpose: Cilengitide is a potent and selective inhibitor of the integrins αvβ3 and αvβ5. The primary objective of this phase I clinical trial was to establish the maximum tolerated dose...
2.
Puls L, Eadens M, Messersmith W
Oncologist
. 2011 Apr;
16(5):566-78.
PMID: 21521831
Summary: Src is believed to play an important role in cancer, and several agents targeting Src are in clinical development. Design: We reviewed Src structure and function and preclinical data...
3.
Spratlin J, Cohen R, Eadens M, Gore L, Camidge D, Diab S, et al.
J Clin Oncol
. 2010 Jan;
28(5):780-7.
PMID: 20048182
PURPOSE To evaluate the safety, maximum-tolerated dose (MTD), pharmacokinetics (PKs), pharmacodynamics, and preliminary anticancer activity of ramucirumab (IMC-1121B), a fully human immunoglobulin G(1) monoclonal antibody targeting the vascular endothelial growth...